CASP3 and sarcoma: Our results indicated that, although ITs promoted the strong activation of caspase 3/7 in both 2D and in 3D sarcoma models, SSs and ORs presented a delayed activation time, compared to ACs (delay of 8 h and 32–56 h, respectively).